Xencor | XNCR - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 608K 2026-06
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amgen USD 541M 1000K 2026-06
Arrowhead Research USD 141.14M 564K 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Cytokinetics USD 124.43M 2.17M 2026-03
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
J&J USD 2.41B 1.64M 2026-06
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
MacroGenics USD 63.56M 241K 2026-03
Merck USD 2.47B 1.05M 2026-06
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Xencor USD 74.33M 265K 2026-06